Five researchers from The Neuro (Montreal Neurological Institute-Hospital) are leading innovative new projects that have received major funding from Canada Foundation for Innovation’s Innovation Fund. They will be funded for a total of $14.5 million, part of $42 million going to McGill University scientists.
A new injectable gel developed by researchers at McGill University and Kyoto University could enable stem cell-based treatments for swallowing disorders.
While stem cells have the potential to repair damaged swallowing muscles, ensuring their survival after injection has been a major challenge. In a preclinical study published in Biomaterials, the new approach improved stem-cell survival by more than five times compared with traditional methods.
Professors Wendell Nii Laryea Adjetey and Jill Baumgartner will lead innovative research focusing on anti-Black carceral systems and climate-related health risks respectively
Pre-teens who struggle to control their video gaming habits are more likely to have psychotic-like experiences a year later, a new study has found.
McGill University researchers and colleagues at Maastricht University found that 12-year-olds who showed signs of problematic gaming were more likely to experience mild paranoia, unusual beliefs or disturbed perceptions at age 13.
Part of the largest CIHR-led cancer prevention investment, McGill researchers will develop approaches to reduce cancer risk and improve early detection
Spending time in nature, even briefly, triggers changes in the brain that calm stress, restore attention and quiet mental clutter, a new study has found.
Researchers at McGill University and colleagues at Adolfo Ibáñez University in Chile have examined more than 100 brain-imaging studies from various disciplines. The result is one of the most comprehensive reviews to date of how the brain responds to nature.
Scientists at McGill University and the Rosalind and Morris Goodman Cancer Institute have developed a new way to deliver cancer immunotherapy that caused fewer side effects compared to standard treatment in a preclinical study.
Scientists have identified a pattern of gene activity present in some female survivors of childhood abuse that is associated with an elevated risk of depression.
Friday February 13 2026 • 3pm to 5pm
McIntyre Building, room 330, 3655 Promenade Sir-William-Osler, Montreal QC, H3A 1A3
56 McGill research projects were awarded funding through CIHR’s Fall 2025 Project Grant competition, to support high-potential health research across all areas and career stages.
The familiar labels “night owl” and “early bird,” long used in sleep research, don’t fully capture the diversity of human internal clocks, a new study has found.
The McGill University-led study published in Nature Communications found the two sleep-wake patterns, called chronotypes, contain a total of five distinct biological subtypes, each associated with different patterns of behaviour and health.
Hydrocephalus is a life-threatening condition that occurs in about 1 in 1,000 newborns and is often treated with invasive surgery. Now, a new study offers hope of preventing hydrocephalus before it even occurs.
A preclinical study published in Nature has found evidence that the hippocampus, the brain region that stores memory, also reorganizes memories to anticipate future outcomes.
A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia.
Drawing on clinical data from more than 450,000 patients, the research adds to growing evidence that incretin-based therapies have protective benefits for the brain.
The study examined GLP-1 receptor agonists, which include such medications as Ozempic, as well as DPP-4 inhibitors.
